XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.22.2

Goodwill and Intangible Assets | 9 Months Ended
--- | ---
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets | 6. Goodwill and Intangible Assets Goodwill represents the excess of net book value over the estimated fair value of net tangible and identifiable intangible assets of a reporting unit. Goodwill is tested for impairment annually or more often if impairment indicators are present at the reporting unit level. If events occur or circumstances change that would more likely than not reduce fair values of the reporting units below their carrying values, goodwill will be evaluated for impairment between annual tests. No triggering events indicating goodwill impairment occurred during the nine months ended June 30, 2022. Please refer to Note 8, "Goodwill and Intangible Assets" to the Company's consolidated financial statements included in the 2021 Annual Report on Form 10-K for further information on the goodwill impairment testing performed during fiscal year 2021. The Company performs its annual goodwill impairment assessment on April 1st of each year. In accordance with ASC 350, Intangibles-Goodwill and Other, the Company initially assesses qualitative factors to determine whether the existence of events or circumstances indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines, based on this assessment, that it is more likely than not that the fair value of the reporting unit is less than its carrying value, it performs a quantitative goodwill impairment test by comparing the reporting unit’s fair value with its carrying value. An impairment loss is recognized for the amount by which the reporting unit’s carrying value exceeds its fair value, up to the total amount of goodwill allocated to the reporting unit. No impairment loss is recognized if the fair value of the reporting exceeds its carrying value. During the quarter ended June 30, 2022, the Company completed the annual goodwill impairment test for each of its reporting units, including the Life Sciences Products reporting unit within the Life Sciences Products segment, and the Life Sciences Services reporting unit within the Life Sciences Services segment. Based on the test results, the Company determined that no adjustment to goodwill was necessary. The Company conducted a qualitative assessment for both the Life Sciences Services and Life Sciences Products reporting units. The Company determined that it was more likely than not that their fair values were greater than their carrying values. As a result of the analysis, the Company did not perform the quantitative assessment for these reporting units, and therefore, did not recognize any impairment losses. The changes in the Company’s goodwill by reportable segment since September 30, 2021 are as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ | ​
​ | ​ | Life Sciences | ​ | Life Sciences | ​ | ​ | ​
​ | ​ | Products | ​ | Services | ​ | Total
Balance, at September 30, 2021 | ​ |  | 110,138 | ​ |  | 359,218 | ​ |  | 469,356
Adjustments | ​ |  | (4,422) | ​ |  | (49) | ​ |  | (4,471)
Balance, at June 30, 2022 | ​ | $ | 105,716 | ​ | $ | 359,169 | ​ | $ | 464,885
​ During the nine months ended June 30, 2022, the Company recorded a goodwill decrease of $4.5 million primarily related to foreign currency translation adjustments. ​ The components of the Company’s identifiable intangible assets as of June 30, 2022 and September 30, 2021 are as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2022 | ​ | September 30, 2021
​ | ​ | ​ | ​ | Accumulated | ​ | Net Book | ​ | ​ | ​ | Accumulated | ​ | Net Book
​ |  | Cost |  | Amortization |  | Value |  | Cost |  | Amortization |  | Value
Patents | ​ | $ | 1,226 | ​ | $ | 1,077 | ​ | $ | 149 | ​ | $ | 1,242 | ​ | $ | 1,002 | ​ | $ | 240
Completed technology | ​ |  | 74,361 | ​ |  | 37,029 | ​ |  | 37,332 | ​ |  | 75,527 | ​ |  | 32,383 | ​ |  | 43,144
Trademarks and trade names | ​ |  | 424 | ​ |  | 56 | ​ |  | 368 | ​ |  | 424 | ​ |  | 33 | ​ |  | 391
Non-competition agreements | ​ | ​ | 681 | ​ | ​ | 391 | ​ | ​ | 290 | ​ | ​ | 681 | ​ | ​ | 249 | ​ | ​ | 432
Customer relationships | ​ |  | 249,277 | ​ |  | 126,725 | ​ |  | 122,552 | ​ |  | 253,486 | ​ |  | 111,159 | ​ |  | 142,327
Other intangibles | ​ | ​ | 220 | ​ | ​ | 220 | ​ | ​ | — | ​ | ​ | 246 | ​ | ​ | 246 | ​ | ​ | —
​ | ​ | $ | 326,189 | ​ | $ | 165,498 | ​ | $ | 160,691 | ​ | $ | 331,606 | ​ | $ | 145,072 | ​ | $ | 186,534
​ Amortization expense for intangible assets was $7.6 million and $9.6 million, respectively, for the three months ended June 30, 2022 and 2021. Amortization expense for intangible assets was $23.4 million and $27.9 million, respectively, for the nine months ended June 30, 2022 and 2021. Estimated future amortization expense for the intangible assets for the remainder of fiscal year 2022, the subsequent four fiscal years and thereafter is as follows (in thousands):
​ | ​ | ​ | ​
2022 | ​ | $ | 6,121
2023 | ​ |  | 30,845
2024 | ​ |  | 27,354
2025 | ​ |  | 22,574
2026 | ​ |  | 19,435
Thereafter | ​ |  | 54,362
​ | ​ | $ | 160,691
​ ​ ​

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration